Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
9 studies found for:    TauRx
Show Display Options
Rank Status Study
1 Completed TRx0014 in Patients With Mild or Moderate Alzheimer's Disease
Condition: Dementia, Alzheimer Type
Interventions: Drug: TRx0014;   Drug: Placebo
2 Completed Multiple Dose Study of TRx0037
Condition: Alzheimer's Disease
Intervention: Drug: TRx0037
3 Completed Open Label Study of TRx0014 in Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: TRx0014
4 Active, not recruiting Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: TRx0237 150 mg/day;   Drug: TRx0237 250 mg/day;   Drug: Placebo
5 Active, not recruiting Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: TRx0237 200 mg/day;   Drug: Placebo
6 Completed Comparative Bioavailability in Healthy Elderly Volunteers
Condition: Alzheimer's Disease
Intervention: Drug: TRx0037
7 Terminated
Has Results
Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: TRx0237;   Drug: Placebo
8 Enrolling by invitation Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Conditions: Alzheimer's Disease;   Behavioral Variant Frontotemporal Dementia
Intervention: Drug: TRx0237
9 Recruiting Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
Condition: Behavioral Variant Frontotemporal Dementia (bvFTD)
Interventions: Drug: TRx0237;   Drug: Placebo

Indicates status has not been verified in more than two years